Answers are grounded in this paper and cite their sources.
The objective of this study is to understand if mitigation controls recommended by the CDC influence a reduction in risk of contracting COVID-19 within the pre-vaccine era of a medical device manufacturing setting. A cross-sectional epidemiological survey that includes 1,136 participants was conducted to assess COVID-19 infection rates across a medical device company with multiple sites located in Indiana between 01JAN2020 to 31DEC2020. Among employees (N=870) who are ever on-site, there is an 86% (OR=0.14, 95% CI:0.043-0.448) reduction in the odds of contracting COVID-19 as compared to employees off-site. Additionally, no COVID-19 related deaths were reported during this period. On-site risk of contracting COVID-19 was lowered through mitigation control measures and financially incentivized leave for self-reporting of COVID-19 exposure and/or symptoms. Thus, the preventative measures taken at this medical device company in southern Indiana reduced morbidity and possibly mortality of their employees.
No takes yet. Share an insight, caveat, or question.
McKechnie et al. (2022) studied this question.